Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1984-3-23
|
pubmed:abstractText |
Antibody 3G8 reacts with the receptor for the Fc fragment of aggregated IgG present on the majority of neutrophilic granulocytes and on a small proportion of lymphocytes. In this report, we compare the pattern of reactivity of antibody 3G8 on peripheral blood lymphocytes (PBL) and on polymorphonuclear leukocytes (PMN) with that of antibody B73.1, which reacts with the Fc receptor of natural killer (NK) cells or with a molecule functionally associated with it. We show that 3G8 reacts with the same PBL subset detected by antibody B73.1 and is responsible for virtually all NK cytotoxic activity. The lymphocyte subset recognized by the two antibodies has the morphology of large granular lymphocytes and includes neither B nor T cells. Our results indicate that NK cells and PMN express the same Fc receptor for immune complexes, and that B73.1 and 3G8 recognize on the same receptor two distinct epitopes that are preferentially expressed on NK cells and on PMN, respectively.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
132
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1410-5
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:6363540-Antibodies, Monoclonal,
pubmed-meshheading:6363540-Antibody Specificity,
pubmed-meshheading:6363540-Antigen-Antibody Reactions,
pubmed-meshheading:6363540-Antigens, Surface,
pubmed-meshheading:6363540-Binding, Competitive,
pubmed-meshheading:6363540-Fluorescent Antibody Technique,
pubmed-meshheading:6363540-Humans,
pubmed-meshheading:6363540-Killer Cells, Natural,
pubmed-meshheading:6363540-Neutrophils,
pubmed-meshheading:6363540-Receptors, Fc
|
pubmed:year |
1984
|
pubmed:articleTitle |
Antibody 3G8, specific for the human neutrophil Fc receptor, reacts with natural killer cells.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|